ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Operating cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $19.5B | +1.2% | 1.6% | 9.7% |
| Operating cash flow (TTM) | $19.5B |
|---|---|
| YoY | +1.2% |
| 5-year CAGR | 1.6% |
| 10-year CAGR | 9.7% |
Operating cash flow
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $19.0B | +1.2% |
| 2024 | $18.8B | −17.7% |
| 2023 | $22.8B | −8.4% |
| 2022 | $24.9B | +9.5% |
| 2021 | $22.8B | +29.5% |
| 2020 | $17.6B | +32.0% |
| 2019 | $13.3B | −0.8% |
| 2018 | $13.4B | +34.8% |
| 2017 | $10.0B | +41.5% |
| 2016 | $7.0B | −6.6% |
| 2015 | $7.5B | +112.3% |
| 2014 | $3.5B | −43.4% |
| 2013 | $6.3B | −1.2% |
| 2012 | $6.3B | +1.6% |
| 2011 | $6.2B | — |